Structures by: Fernandes P.

Total: 35

10,11-Dihydro-5H-dibenzo(a,d)cycloheptene-5-carboxamide

C16H15NO

Florence, A. J.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.Leech, C. K.

CrystEngComm (2008) 10, 1 26

a=5.6491(1)Å   b=19.5639(4)Å   c=22.0741(5)Å

α=84.2178(13)°   β=88.4073(14)°   γ=83.6001(13)°

Cytenamide form II

C16H13N1O1

Florence, A. J.Bedford, C. T.Fabbiani, F. P. A.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.

CrystEngComm (2008) 10, 7 811

a=5.8100(2)Å   b=19.6315(5)Å   c=21.7087(6)Å

α=85.918(2)°   β=86.164(2)°   γ=84.482(2)°

Cytenamide form I

C16H13N1O1

Florence, A. J.Bedford, C. T.Fabbiani, F. P. A.Shankland, K.Gelbrich, T.Hursthouse, M. B.Shankland, N.Johnston, A.Fernandes, P.

CrystEngComm (2008) 10, 7 811

a=33.9078(10)Å   b=33.9078(10)Å   c=5.6754(2)Å

α=90°   β=90°   γ=120°

Creatine form II

C4H9N3O2

Arlin, Jean-BaptisteBhardwaj, Rajni M.Johnston, AndreaMiller, Gary J.Bardin, JulieMacDougall, FionaFernandes, PhilippeShankland, KennethDavid, William I. F.Florence, Alastair J.

CrystEngComm (2014) 16, 35 8197

a=9.8450(3)Å   b=5.8373(2)Å   c=11.6698(3)Å

α=90°   β=105.723(2)°   γ=90°

Creatine formic acid solvate

C4H9N3O2,CH2O2

Arlin, Jean-BaptisteBhardwaj, Rajni M.Johnston, AndreaMiller, Gary J.Bardin, JulieMacDougall, FionaFernandes, PhilippeShankland, KennethDavid, William I. F.Florence, Alastair J.

CrystEngComm (2014) 16, 35 8197

a=17.4929(14)Å   b=4.7791(4)Å   c=10.1101(8)Å

α=90.00°   β=90.00°   γ=90.00°

Creatine form II

C4H9N3O2

Arlin, Jean-BaptisteBhardwaj, Rajni M.Johnston, AndreaMiller, Gary J.Bardin, JulieMacDougall, FionaFernandes, PhilippeShankland, KennethDavid, William I. F.Florence, Alastair J.

CrystEngComm (2014) 16, 35 8197

a=9.8450(3)Å   b=5.8373(2)Å   c=11.6698(3)Å

α=90°   β=105.723(2)°   γ=90°

Creatine formic acid solvate

C4H9N3O2,CH2O2

Arlin, Jean-BaptisteBhardwaj, Rajni M.Johnston, AndreaMiller, Gary J.Bardin, JulieMacDougall, FionaFernandes, PhilippeShankland, KennethDavid, William I. F.Florence, Alastair J.

CrystEngComm (2014) 16, 35 8197

a=17.4929(14)Å   b=4.7791(4)Å   c=10.1101(8)Å

α=90.00°   β=90.00°   γ=90.00°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C7H6ClN3O4S2

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8481(16)Å   b=6.359(2)Å   c=8.900(3)Å

α=74.49(3)°   β=83.90(3)°   γ=80.53(3)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C7H6ClN3O4S2

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8619(17)Å   b=6.377(2)Å   c=8.926(3)Å

α=74.40(3)°   β=83.93(3)°   γ=80.56(3)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C7H6ClN3O4S2

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8707(9)Å   b=6.3951(12)Å   c=8.9448(16)Å

α=74.368(16)°   β=83.786(14)°   γ=80.459(15)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C7H6ClN3O4S2

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8737(9)Å   b=6.4046(13)Å   c=8.9548(16)Å

α=74.324(17)°   β=83.751(15)°   γ=80.449(16)°

6-chloro-1,1-dioxo-2H-1,2,4-benzothiadiazine-7-sulfonamide

C7H6ClN3O4S2

Fernandes, P.Shankland, K.David, W. I. F.Markvardsen, A. J.Florence, A. J.Shankland, N.Leech, C. K.

Journal of Applied Crystallography (2008) 41, 6 1089-1094

a=4.8786(9)Å   b=6.4126(13)Å   c=8.9665(16)Å

α=74.266(16)°   β=83.693(15)°   γ=80.445(16)°

Dibenz[a,c]anthracene

C22H14

Fernandes, PhilippeFlorence, AlastairShankland, Kenneth David, Bill

Acta Crystallographica Section E (2005) 61, 5 o1483-o1485

a=18.2966(5)Å   b=5.06225(10)Å   c=15.7245(4)Å

α=90°   β=104.5574(15)°   γ=90°

3-Azabicyclo[3.3.1]nonane-2,4-dione

C8H11N1O2

Hulme, Ashley TFernandes, PhilippeFlorence, AlastairJohnston, AndreaShankland, Kenneth

Acta Crystallographica Section E (2006) 62, 7 o3046-o3048

a=7.67102(18)Å   b=10.5483(2)Å   c=18.8867(4)Å

α=90°   β=95.5800(12)°   γ=90°

Hydrochlorothiazide form II

C7H8ClN3O4S2

Florence, AlastairJohnston, AndreaFernandes, PhilippeShankland, KennethStevens, Howard N. E.Osmundsen, SigrunnMullen, Alexander B.

Acta Crystallographica Section E (2005) 61, 9 o2798-o2800

a=9.4884(5)Å   b=8.3334(4)Å   c=15.1309(7)Å

α=90°   β=113.2087(19)°   γ=90°

Chlorothiazide dimethylformamide solvate

C7H6ClN3O4S2,C3H7NO

Fernandes, PhilippeFlorence, Alastair J.Shankland, Kenneth Shankland, NormanJohnston, Andrea

Acta Crystallographica Section E (2006) 62, 6 o2216-o2218

a=7.9822(4)Å   b=8.8830(5)Å   c=11.1075(6)Å

α=86.689(3)°   β=75.078(3)°   γ=73.196(3)°

(R)-1-phenylethylammonium (R)-2-phenylbutyrate

C8H12N,C10H11O2

Fernandes, PhilippeFlorence, AlastairShankland, Kenneth Karamertzanis, PanosHulme, Ashley TAnandamanoharan, Parathay

Acta Crystallographica Section E (2007) 63, 1 o247-o249

a=6.06200(10)Å   b=16.7794(3)Å   c=16.8881(4)Å

α=90°   β=90°   γ=90°

Trichlormethiazide

C8H8Cl3N3O4S2

Fernandes, PhilippeLeech, Charlotte K.Johnston, AndreaShankland, KennethDavid, William I. F.Shankland, NormanFlorence, Alastair J.

Acta Crystallographica Section E (2007) 63, 9 o3685-o3685

a=8.7881(2)Å   b=9.7924(2)Å   c=15.8527(3)Å

α=90.00°   β=90.00°   γ=90.00°

Carbamazepine trifluoroacetic acid solvate

C15H12N2O,C2HF3O2

Fernandes, PhilippeBardin, JulieJohnston, AndreaFlorence, Alastair J.Leech, Charlotte K.David, William I. F.Shankland, Kenneth

Acta Crystallographica Section E (2007) 63, 11 o4269-o4269

a=15.0142(4)Å   b=5.28710(10)Å   c=20.2489(6)Å

α=90.00°   β=101.735(3)°   γ=90.00°

Urea DMF solvate (3/1)

C3H7NO,3(CH4N2O)

Fernandes, PhilippeFlorence, Alastair J.Fabbiani, FrancescaDavid, William I. F.Shankland, Kenneth

Acta Crystallographica Section E (2007) 63, 12 o4861-o4861

a=7.5246(13)Å   b=9.866(4)Å   c=10.821(4)Å

α=65.61(4)°   β=79.43(2)°   γ=70.76(2)°

Dihydrocarbamazepine formamide

C15H14N2O,CH3NO

Johnston, AndreaFlorence, Alastair J.Fernandes, PhilippeShankland, NormanKennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 9 o3888-o3889

a=8.4690(4)Å   b=9.0215(4)Å   c=10.3137(4)Å

α=74.363(3)°   β=83.630(3)°   γ=70.847(3)°

10,11-Dihydrocarbamazepine--dimethyl sulfoxide (1/1)

C15H14N2O1,C2H6OS

Johnston, AndreaFlorence, Alastair J.Shankland, KennethLeech, Charlotte K.Shankland, NormanFernandes, Philippe

Acta Crystallographica Section E (2007) 63, 9 o3918-o3919

a=10.2696(3)Å   b=6.8543(2)Å   c=23.3599(6)Å

α=90.00°   β=98.932(2)°   γ=90.00°

3-azabicyclo[3.3.1]nonane-2,4-dione 1-methylnaphthalene hemisolvate

C8H11NO2,0.5C11H10

Hulme, Ashley TFernandes, PhilippeFlorence, AlastairJohnston, AndreaShankland, Kenneth

Acta Crystallographica Section E (2006) 62, 9 o3752-o3754

a=15.02360(18)Å   b=7.32295(12)Å   c=22.5164(3)Å

α=90°   β=106.0201(6)°   γ=90°

10,11-Dihydrocarbamazepine--formic acid (1/1)

C15H14N2O,CH2O2

Johnston, AndreaFlorence, Alastair J.Fernandes, PhilippeShankland, NormanKennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 3 o1469-o1470

a=5.2298(4)Å   b=9.3849(12)Å   c=14.4858(18)Å

α=83.853(5)°   β=88.230(7)°   γ=88.221(7)°

Hydroflumethiazide dimethylsulfoxide disolvate

C8H8F3N3O4S2,2C2H6OS

Fernandes, PhilippeJohnston, AndreaLeech, Charlotte K.Shankland, KennethDavid, William I. F.Florence, Alastair J.

Acta Crystallographica Section E (2007) 63, 10 o3956-o3956

a=5.55700(10)Å   b=20.8433(4)Å   c=17.4142(3)Å

α=90.00°   β=93.540(2)°   γ=90.00°

Urea--dimethylacetamide

C4H9NO,CH4N2O

Fernandes, PhilippeFlorence, Alastair J.Fabbiani, FrancescaDavid, William I. F.Shankland, Kenneth

Acta Crystallographica Section E (2008) 64, 2 o355-o355

a=7.2770(3)Å   b=17.5394(9)Å   c=7.3789(4)Å

α=90°   β=119.450(3)°   γ=90°

10,11-Dihydrocarbamazepine--acetic acid (1/1)

C15H14N2O,C2H4O2

Johnston, AndreaFlorence, Alastair J.Fernandes, PhilippeShankland, NormanKennedy, Alan R.

Acta Crystallographica Section E (2006) 62, 12 o5361-o5362

a=5.3104(4)Å   b=15.4246(17)Å   c=18.732(2)Å

α=90.00°   β=95.106(7)°   γ=90.00°

(R)-1-phenylethylammonium (R)-2-phenylbutyrate

C8H12N,C10H11O2

Fernandes, PhilippeFlorence, Alastair J.Shankland, KennethKaramertzanis, G. PanagiotisHulme, Ashley T.Anandamanoharan, R. Parathy

Acta Crystallographica Section E (2007) 63, 1 o202-o204

a=11.88215(15)Å   b=5.97647(8)Å   c=13.07499(15)Å

α=90°   β=113.5100(10)°   γ=90°

Chlorothiazide DMSO solvate

C7H6ClN3O4S2,C2H6OS

Johnston, AndreaFlorence, Alastair J.Fernandes, PhilippeKennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 5 o2423-o2423

a=9.0965(3)Å   b=11.2081(4)Å   c=15.8916(5)Å

α=109.009(2)°   β=103.384(2)°   γ=96.246(2)°

Chlorothiazide N,N-dimethylacetamide solvate

C7H6ClN3O4S2,2C4H9NO

Johnston, AndreaFlorence, Alastair J.Fernandes, PhilippeKennedy, Alan R.

Acta Crystallographica Section E (2007) 63, 5 o2422-o2422

a=8.2037(3)Å   b=24.5226(6)Å   c=10.6443(3)Å

α=90.00°   β=105.231(2)°   γ=90.00°

Bendroflumethiazide acetone solvate

C15H14F3N3O4S2,C3H6O

Fabbiani, Francesca P. A.Leech, Charlotte K.Shankland, KennethJohnston, AndreaFernandes, PhilippeFlorence, Alastair J.Shankland, Norman

Acta Crystallographica Section C (2007) 63, 11 o659-o663

a=8.192(2)Å   b=9.525(2)Å   c=14.101(2)Å

α=99.538(17)°   β=100.171(17)°   γ=100.42(2)°

Bendroflumethiazide N,N-dimethylformamide solvate

C15H14F3N3O4S2,C3H7NO

Fabbiani, Francesca P. A.Leech, Charlotte K.Shankland, KennethJohnston, AndreaFernandes, PhilippeFlorence, Alastair J.Shankland, Norman

Acta Crystallographica Section C (2007) 63, 11 o659-o663

a=8.2527(3)Å   b=17.8431(7)Å   c=14.9012(5)Å

α=90°   β=103.752(4)°   γ=90°